GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » 3-Year EPS without NRI Growth Rate

Omid Holdings (Omid Holdings) 3-Year EPS without NRI Growth Rate : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings 3-Year EPS without NRI Growth Rate?

Omid Holdings's EPS without NRI for the three months ended in . 20 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Competitive Comparison of Omid Holdings's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Omid Holdings's 3-Year EPS without NRI Growth Rate falls into.



Omid Holdings 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Omid Holdings  (OTCPK:OMID) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Omid Holdings 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Omid Holdings's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Launches New Products and Marketing

By PRNewswire PRNewswire 06-16-2020

OMID Holdings, Inc. Issues a Letter to Shareholders

By PRNewswire PRNewswire 02-26-2020

OMID Provides Fourth-Quarter Financial Highlights

By PRNewswire PRNewswire 01-14-2021

AV1 Group, Inc. Announces LOI

By Marketwired Marketwired 05-08-2019

OMID Announces Reduction of Common Shares

By PRNewswire PRNewswire 06-24-2021

OMID Holdings, Inc. Issues Shareholder Letter

By PRNewswire PRNewswire 03-02-2021

OMID Posts Second Quarter Financial Statements

By PRNewswire PRNewswire 08-10-2021

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020